Key Details
The Minister used progress in quantum communication and biotechnology to make the case for closer ties between research institutions and firms.
Research partnerships: Industry should identify technical needs and potential markets at the start of research projects, rather than become involved only after a technology has been developed.
Commercialisation: Industry bodies can connect scientists and start-ups with businesses and investment to help move technologies from laboratories to commercial use.
Quantum communication: Singh cited a 1,000-km quantum-secure communication milestone against the National Quantum Mission’s eight-year goal of 2,000 km. The milestone had been reported earlier; it was not newly achieved at this session.
Bioeconomy: He put its size at about US$195 billion and reiterated the ambition of US$300 billion by 2030. These are figures and a target cited in his address.
Research finance: He called for greater private-sector participation alongside the government’s Research, Development and Innovation (RDI) initiative.
Industry Involvement Is the Main Policy Signal
Singh’s argument was that scientific capability alone does not ensure commercial success. If firms help define a problem early, researchers can better understand the performance, cost and scale a prospective customer needs. Industry can then help test and finance a technology as it moves beyond the laboratory.
He linked this approach to strategic sovereignty: developing Indian technologies that can compete globally, rather than relying primarily on technologies developed elsewhere. He pointed to space, quantum communication and biotechnology as areas where domestic research and private participation could work together. The quantum and bioeconomy figures illustrated his case; the request for earlier, deeper industry engagement was the substance of this speech.
Policy Relevance
For research institutions: Industry partnerships could make commercial requirements visible before a project is too far advanced to adapt.
For firms and industry bodies: Participation entails more than purchasing finished technology; it can include defining needs, testing prototypes and committing investment.
For public research support: The relevant measure of progress is not only research activity, but whether promising technologies can be developed, validated and produced at a useful scale.
Relevant Question for Policy Stakeholders: How can publicly supported research projects bring in credible industry partners early without narrowing research solely to near-term commercial needs?
Follow the Full Press Release Here: Dr. Jitendra Singh’s Address at PHDCCI’s 121st Annual Session